Skip to main content
Top
Published in: Current Bladder Dysfunction Reports 1/2023

28-11-2022 | Acupuncture | Outcomes in Functional Urology (A Cameron, Section Editor)

Quality, Value, and Efficacy of Complementary and Alternative Medicine in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome

Authors: Béatrice Bouchard, Lysanne Campeau

Published in: Current Bladder Dysfunction Reports | Issue 1/2023

Login to get access

Abstract

Purpose of Review

Interstitial cystitis/bladder pain syndrome (IC/BPS) is a difficult condition to treat, and few treatments have been demonstrated to be effective. Patients are therefore often willing to try treatments that traditional medicine does not offer, such as complementary and alternative medicine (CAM). The purpose of this paper is to review the current CAM treatments for IC/BPS.

Recent Findings

Several modalities have been explored in the treatment of IC/BPS. Dietary modification with the elimination of arylalkylamine-containing foods has been shown to reduce symptom flares. Different nutraceuticals have also been studied. Promising results were shown for calcium glycerophosphate taken before the ingestion of foods responsible for symptom flares. The glycosaminoglycan layer appears to be damaged in this condition, and therefore intravesical and oral therapies targeting this layer have the potential of improving symptoms. Mind–body interventions including yoga, mindfulness-based stress reduction, and hypnosis can improve symptoms, relaxation, and help patients in feeling more empowered. Manipulative approaches such as myofascial physical therapy, transvaginal biofeedback, and intravaginal Thiele massage can improve pelvic floor hypertonicity. Pulsed electromagnetic field therapy and acupuncture with or without moxibustion are associated with a reduction in pain.

Summary

Different areas of complementary and alternative medicine have been studied for the treatment of IC/BPS, including biologically based therapies, mind-body interventions, manipulative and body-based approaches, and whole medical systems. These therapies have shown promising results. However, most of them have a small number of participants and do not provide high-quality evidence regarding their effectiveness. Randomized, placebo-controlled studies should be conducted to establish the efficacy of CAMs.
Literature
1.
go back to reference •• Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208:34–42. (New amendments have been made to the American Urological Association Guidelines on Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome. This guideline provides information with IC/BPS epidemiology, diagnosis, and treatment. Behavioral and non-pharmacological therapies are part of the treatment algorithm. Non-pharmacological treatments that are recommended include self-care practices, stress management, and physical therapy techniques.)CrossRefPubMed •• Clemens JQ, Erickson DR, Varela NP, Lai HH. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome. J Urol. 2022;208:34–42. (New amendments have been made to the American Urological Association Guidelines on Diagnosis and Treatment Interstitial Cystitis/Bladder Pain Syndrome. This guideline provides information with IC/BPS epidemiology, diagnosis, and treatment. Behavioral and non-pharmacological therapies are part of the treatment algorithm. Non-pharmacological treatments that are recommended include self-care practices, stress management, and physical therapy techniques.)CrossRefPubMed
2.
go back to reference Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014;175:30–7.CrossRefPubMed Davis NF, Brady CM, Creagh T. Interstitial cystitis/painful bladder syndrome: epidemiology, pathophysiology and evidence-based treatment options. Eur J Obstet Gynecol Reprod Biol. 2014;175:30–7.CrossRefPubMed
3.
go back to reference •• Soriano AJ, Schnur JB, Harvie HS, Newman DK, Montgomery GH, Arya LA. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol Urodyn. 2021;40:1945–54. (Hypnosis for IC/BPS is not extensively present in the literature. This is one of the first articles with a robust methodology that evaluates its effects. This study demonstrates that a randomized, controlled, trial for hypnosis in women with IC/BPS is feasible and acceptable. This study also shows potential benefits in terms of symptom reduction and improved quality of life.)CrossRefPubMed •• Soriano AJ, Schnur JB, Harvie HS, Newman DK, Montgomery GH, Arya LA. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol Urodyn. 2021;40:1945–54. (Hypnosis for IC/BPS is not extensively present in the literature. This is one of the first articles with a robust methodology that evaluates its effects. This study demonstrates that a randomized, controlled, trial for hypnosis in women with IC/BPS is feasible and acceptable. This study also shows potential benefits in terms of symptom reduction and improved quality of life.)CrossRefPubMed
4.
go back to reference O’Hare PG, Hoffmann AR, Allen P, Gordon B, Salin L, Whitmore K. Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecol J. 2012;24:977–82.CrossRefPubMed O’Hare PG, Hoffmann AR, Allen P, Gordon B, Salin L, Whitmore K. Interstitial cystitis patients’ use and rating of complementary and alternative medicine therapies. Int Urogynecol J. 2012;24:977–82.CrossRefPubMed
5.
go back to reference Pearson NJ, Chesney MA. The National Center for Complementary and Alternative Medicine. Acad Med. 2007;82:967.CrossRefPubMed Pearson NJ, Chesney MA. The National Center for Complementary and Alternative Medicine. Acad Med. 2007;82:967.CrossRefPubMed
6.
go back to reference Whitmore KE. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol. 2002;4Suppl(Suppl 1):S28–35. Whitmore KE. Complementary and alternative therapies as treatment approaches for interstitial cystitis. Rev Urol. 2002;4Suppl(Suppl 1):S28–35.
7.
go back to reference Gillespie L. Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol. 1993;72:293–7.CrossRefPubMed Gillespie L. Metabolic appraisal of the effects of dietary modification on hypersensitive bladder symptoms. Br J Urol. 1993;72:293–7.CrossRefPubMed
9.
go back to reference Oh-oka H. Clinical efficacy of 1-year intensive systematic dietary manipulation as complementary and alternative medicine therapies on female patients with interstitial cystitis/bladder pain syndrome. Urol. 2017;106:50–4.CrossRefPubMed Oh-oka H. Clinical efficacy of 1-year intensive systematic dietary manipulation as complementary and alternative medicine therapies on female patients with interstitial cystitis/bladder pain syndrome. Urol. 2017;106:50–4.CrossRefPubMed
10.
go back to reference Pang R, Ali A. The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome. Transl Androl Urol. 2015;4(6):653–61. PubMedPubMedCentral Pang R, Ali A. The Chinese approach to complementary and alternative medicine treatment for interstitial cystitis/bladder pain syndrome. Transl Androl Urol. 2015;4(6):653–61. PubMedPubMedCentral
11.
go back to reference Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109:1584–91.CrossRefPubMed Friedlander JI, Shorter B, Moldwin RM. Diet and its role in interstitial cystitis/bladder pain syndrome (IC/BPS) and comorbid conditions. BJU Int. 2012;109:1584–91.CrossRefPubMed
12.
go back to reference Bologna RA, Gomelsky A, Lukban JC, Tu LM, Holzberg AS, Whitmore KE. The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology. 2001;57:119–20.CrossRefPubMed Bologna RA, Gomelsky A, Lukban JC, Tu LM, Holzberg AS, Whitmore KE. The efficacy of calcium glycerophosphate in the prevention of food-related flares in interstitial cystitis. Urology. 2001;57:119–20.CrossRefPubMed
13.
go back to reference • Okuyama E, Kawatani M, Hashimoto J, Tanimoto K, Hashimoto M, Matsumoto-Miyai K. The nitric oxide-cyclic guanosine monophosphate pathway inhibits the bladder ATP release in response to a physiological or pathological stimulus. Physiol Rep. 2021. https://doi.org/10.14814/phy2.14938. (The mechanism by which NO and NOS were involved in IC/BPS is not completely understood. This recent study further explores its role and the nitric oxide–cyclic guanosine monophosphate pathway under physiological and pathological circumstances.)CrossRefPubMedPubMedCentral • Okuyama E, Kawatani M, Hashimoto J, Tanimoto K, Hashimoto M, Matsumoto-Miyai K. The nitric oxide-cyclic guanosine monophosphate pathway inhibits the bladder ATP release in response to a physiological or pathological stimulus. Physiol Rep. 2021. https://​doi.​org/​10.​14814/​phy2.​14938. (The mechanism by which NO and NOS were involved in IC/BPS is not completely understood. This recent study further explores its role and the nitric oxide–cyclic guanosine monophosphate pathway under physiological and pathological circumstances.)CrossRefPubMedPubMedCentral
15.
go back to reference Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.CrossRefPubMed Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.CrossRefPubMed
16.
go back to reference Cartledge JJ, Davies A-M, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of l-arginine in the treatment of interstitial cystitis. BJU Int. 2000;85:421–6.CrossRefPubMed Cartledge JJ, Davies A-M, Eardley I. A randomized double-blind placebo-controlled crossover trial of the efficacy of l-arginine in the treatment of interstitial cystitis. BJU Int. 2000;85:421–6.CrossRefPubMed
17.
go back to reference Sahiner IF, Soylu H, Ates E, Acar N, Ustunel I, Danısman A. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model. Int Braz J Urol. 2018;44:1014–22.CrossRefPubMedPubMedCentral Sahiner IF, Soylu H, Ates E, Acar N, Ustunel I, Danısman A. Impact of intravesical hyaluronic acid treatment on bladder inflammation in interstitial cystitis rat model. Int Braz J Urol. 2018;44:1014–22.CrossRefPubMedPubMedCentral
18.
go back to reference • Abdal Dayem A, Kim K, Lee SB, Kim A, Cho S-G. Application of adult and pluripotent stem cells in interstitial cystitis/bladder pain syndrome therapy: methods and perspectives. J Clin Med. 2020;9:766. (This article provides a review of the most recent understandings on the pathophysiology and etiology of IC/BPS. It also discusses a novel therapeutic approach: the potential of stem cells in bladder regeneration and its possible applications in IC/BPS treatment.)CrossRefPubMedCentral • Abdal Dayem A, Kim K, Lee SB, Kim A, Cho S-G. Application of adult and pluripotent stem cells in interstitial cystitis/bladder pain syndrome therapy: methods and perspectives. J Clin Med. 2020;9:766. (This article provides a review of the most recent understandings on the pathophysiology and etiology of IC/BPS. It also discusses a novel therapeutic approach: the potential of stem cells in bladder regeneration and its possible applications in IC/BPS treatment.)CrossRefPubMedCentral
19.
go back to reference Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996;156:45–8.CrossRefPubMed Morales A, Emerson L, Nickel JC, Lundie M. Intravesical hyaluronic acid in the treatment of refractory interstitial cystitis. J Urol. 1996;156:45–8.CrossRefPubMed
20.
go back to reference Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol. 2002;1:1454–8. Steinhoff G, Ittah B, Rowan S. The efficacy of chondroitin sulfate 0.2% in treating interstitial cystitis. Can J Urol. 2002;1:1454–8.
21.
go back to reference Theoharides TC, Kempuraj D, Vakali S, Sant GR. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek—an oral multi-agent natural supplement. Can J Urol. 2008;6:411–4. Theoharides TC, Kempuraj D, Vakali S, Sant GR. Treatment of refractory interstitial cystitis/painful bladder syndrome with CystoProtek—an oral multi-agent natural supplement. Can J Urol. 2008;6:411–4.
22.
go back to reference Meng E, Hsu Y-C, Chuang Y-C. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). LUTS: Lower Urin Tract Symptoms. 2018;10:3–11.CrossRef Meng E, Hsu Y-C, Chuang Y-C. Advances in intravesical therapy for bladder pain syndrome (BPS)/interstitial cystitis (IC). LUTS: Lower Urin Tract Symptoms. 2018;10:3–11.CrossRef
24.
go back to reference Tyagi P, Kashyap M, Majima T, Kawamorita N, Yoshizawa T, Yoshimura N. Intravesical liposome therapy for interstitial cystitis. Int J Urol. 2017;24:262–71.CrossRefPubMed Tyagi P, Kashyap M, Majima T, Kawamorita N, Yoshizawa T, Yoshimura N. Intravesical liposome therapy for interstitial cystitis. Int J Urol. 2017;24:262–71.CrossRefPubMed
25.
go back to reference Chuang Y-C, Lee W-C, Lee W-C, Chiang P-H. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol. 2009;182:1393–400.CrossRefPubMed Chuang Y-C, Lee W-C, Lee W-C, Chiang P-H. Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis/painful bladder syndrome. J Urol. 2009;182:1393–400.CrossRefPubMed
26.
go back to reference Peters KM, Kasenau DL, Anthony M, Kaufman J, Killinger KA. Novel therapy with intravesical liposomes for ulcerative interstitial cystitis/painful bladder syndrome. LUTS: Lower Urin Tract Symptoms. 2011;4:51–3.CrossRef Peters KM, Kasenau DL, Anthony M, Kaufman J, Killinger KA. Novel therapy with intravesical liposomes for ulcerative interstitial cystitis/painful bladder syndrome. LUTS: Lower Urin Tract Symptoms. 2011;4:51–3.CrossRef
28.
go back to reference Huang AJ, Rowen TS, Abercrombie P, Subak LL, Schembri M, Plaut T, Chao MT. Development and feasibility of a group-based therapeutic yoga program for women with chronic pelvic pain. Pain Med. 2017;18:1864–72.CrossRefPubMedPubMedCentral Huang AJ, Rowen TS, Abercrombie P, Subak LL, Schembri M, Plaut T, Chao MT. Development and feasibility of a group-based therapeutic yoga program for women with chronic pelvic pain. Pain Med. 2017;18:1864–72.CrossRefPubMedPubMedCentral
29.
go back to reference Ripoll E, Mahowald D. Hatha yoga therapy management of urologic disorders. World J Urol. 2002;20:306–9.CrossRefPubMed Ripoll E, Mahowald D. Hatha yoga therapy management of urologic disorders. World J Urol. 2002;20:306–9.CrossRefPubMed
30.
go back to reference Soriano AJ, Schnur JB, Harvie HS, Newman DK, Montgomery GH, Arya LA. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol Urodyn. 2021;40:1945–54.CrossRefPubMed Soriano AJ, Schnur JB, Harvie HS, Newman DK, Montgomery GH, Arya LA. Pilot randomized controlled trial of a hypnosis intervention for women with bladder pain syndrome. Neurourol Urodyn. 2021;40:1945–54.CrossRefPubMed
31.
go back to reference Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545–53.CrossRefPubMed Hanno PM, Erickson D, Moldwin R, Faraday MM. Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment. J Urol. 2015;193:1545–53.CrossRefPubMed
32.
go back to reference •• El-Hefnawy AS, Soliman HM, Abd-Elbary SO, Shereif WI. Long-standing nonulcerative bladder pain syndrome: impact of Thiele massage on bladder and sexual domains. LUTS: Lower Urin Tract Symptoms. 2019;12:123–7. (This is one of the first studies specifically evaluating the impacts of Thiele massage on sexual function in IC/BPS, in addition to pain symptoms. The authors concluded that Thiele massage can have some positive impacts on pain symptoms, but that this technique should not be used as monotherapy. Importantly, Thiele massage appears to be associated with a negative impact on vaginal lubrication and increased vaginal dryness.)CrossRef •• El-Hefnawy AS, Soliman HM, Abd-Elbary SO, Shereif WI. Long-standing nonulcerative bladder pain syndrome: impact of Thiele massage on bladder and sexual domains. LUTS: Lower Urin Tract Symptoms. 2019;12:123–7. (This is one of the first studies specifically evaluating the impacts of Thiele massage on sexual function in IC/BPS, in addition to pain symptoms. The authors concluded that Thiele massage can have some positive impacts on pain symptoms, but that this technique should not be used as monotherapy. Importantly, Thiele massage appears to be associated with a negative impact on vaginal lubrication and increased vaginal dryness.)CrossRef
33.
go back to reference FitzGerald MP, Payne CK, Lukacz ES, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187:2113–8.CrossRefPubMedPubMedCentral FitzGerald MP, Payne CK, Lukacz ES, et al. Randomized multicenter clinical trial of myofascial physical therapy in women with interstitial cystitis/painful bladder syndrome and pelvic floor tenderness. J Urol. 2012;187:2113–8.CrossRefPubMedPubMedCentral
35.
go back to reference Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, Whitmore KE. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urol. 2004;64:862–5.CrossRefPubMed Oyama IA, Rejba A, Lukban JC, Fletcher E, Kellogg-Spadt S, Holzberg AS, Whitmore KE. Modified Thiele massage as therapeutic intervention for female patients with interstitial cystitis and high-tone pelvic floor dysfunction. Urol. 2004;64:862–5.CrossRefPubMed
36.
go back to reference Abe-Takahashi Y, Kitta T, Ouchi M, Chiba H, Higuchi M, Togo M, Shinohara N. Examination of pelvic floor muscle elasticity in patients with interstitial cystitis/bladder pain syndrome using real-time tissue elastography. Int Urogynecol J. 2021;33:619–26.CrossRefPubMed Abe-Takahashi Y, Kitta T, Ouchi M, Chiba H, Higuchi M, Togo M, Shinohara N. Examination of pelvic floor muscle elasticity in patients with interstitial cystitis/bladder pain syndrome using real-time tissue elastography. Int Urogynecol J. 2021;33:619–26.CrossRefPubMed
37.
go back to reference • Ross CL, Zhou Y, McCall CE, Soker S, Criswell TL. The use of pulsed electromagnetic field to modulate inflammation and improve tissue regeneration: a review. Bioelectricity. 2019;1:247–59. (This is a review of the published data on the use of PEMF to improve tissue regeneration, as well as its effects on immunomodulatory cells and modulation of inflammatory signaling pathways. The studies included in this article have focused on the effects of PEMF on human and animal tissues and demonstrate its modulatory activity in different stages of the inflammatory response through regulation of pro and anti-inflammatory cytokine secretion.)CrossRefPubMedPubMedCentral • Ross CL, Zhou Y, McCall CE, Soker S, Criswell TL. The use of pulsed electromagnetic field to modulate inflammation and improve tissue regeneration: a review. Bioelectricity. 2019;1:247–59. (This is a review of the published data on the use of PEMF to improve tissue regeneration, as well as its effects on immunomodulatory cells and modulation of inflammatory signaling pathways. The studies included in this article have focused on the effects of PEMF on human and animal tissues and demonstrate its modulatory activity in different stages of the inflammatory response through regulation of pro and anti-inflammatory cytokine secretion.)CrossRefPubMedPubMedCentral
38.
go back to reference Sutbeyaz ST, Sezer N, Koseoglu F, Kibar S. Low-frequency pulsed electromagnetic field therapy in fibromyalgia. Clin J Pain. 2009;25:722–8.CrossRefPubMed Sutbeyaz ST, Sezer N, Koseoglu F, Kibar S. Low-frequency pulsed electromagnetic field therapy in fibromyalgia. Clin J Pain. 2009;25:722–8.CrossRefPubMed
39.
go back to reference •• Wolff DT, Ross C, Lee P, Badlani G, Matthews CA, Evans RJ, Walker SJ. Pulsed electromagnetic field therapy for pain management in interstitial cystitis/bladder pain syndrome: a proof-of-concept case series. Urol. 2022. https://doi.org/10.1016/j.urology.2022.05.021. (This is a single-center, prospective clinical case series that explored the efficacy of PEMF therapy for symptom improvement in females with IC/BPS. Most of the studies prior to this article reported anecdotal experiences with PEMF in females with IC/BPS or its effects in vitro. To our knowledge, this is one of the first studies with a robust methodology that evaluates a larger number of cases. PEMF showed promising results in both symptom quality of life improvement. The authors encouraged further studies to be conducted in this direction.)CrossRefPubMed •• Wolff DT, Ross C, Lee P, Badlani G, Matthews CA, Evans RJ, Walker SJ. Pulsed electromagnetic field therapy for pain management in interstitial cystitis/bladder pain syndrome: a proof-of-concept case series. Urol. 2022. https://​doi.​org/​10.​1016/​j.​urology.​2022.​05.​021. (This is a single-center, prospective clinical case series that explored the efficacy of PEMF therapy for symptom improvement in females with IC/BPS. Most of the studies prior to this article reported anecdotal experiences with PEMF in females with IC/BPS or its effects in vitro. To our knowledge, this is one of the first studies with a robust methodology that evaluates a larger number of cases. PEMF showed promising results in both symptom quality of life improvement. The authors encouraged further studies to be conducted in this direction.)CrossRefPubMed
40.
go back to reference Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.CrossRefPubMed Koskela LR, Thiel T, Ehrén I, De Verdier PJ, Wiklund NP. Localization and expression of inducible nitric oxide synthase in biopsies from patients with interstitial cystitis. J Urol. 2008;180:737–41.CrossRefPubMed
41.
go back to reference Honjo H, Ukimura O, Hirahara N, Ushijima S, Kawauchi A, Kitakoji H, Nakao M, Miki T. 1528: Acupuncture normarized bladder sensory dysfunction of C-fiber in patients with overactive bladder and interstitial cystitis. J Urol. 2007;177:504–5.CrossRef Honjo H, Ukimura O, Hirahara N, Ushijima S, Kawauchi A, Kitakoji H, Nakao M, Miki T. 1528: Acupuncture normarized bladder sensory dysfunction of C-fiber in patients with overactive bladder and interstitial cystitis. J Urol. 2007;177:504–5.CrossRef
42.
go back to reference Katayama Y, Nakahara K, Shitamura T, Mukai S, Wakeda H, Yamashita Y, Inoue K, Nose K, Kamoto T. Effectiveness of acupuncture and moxibustion therapy for the treatment of refractory interstitial cystitis. Hinokika Kiyo. 2013;5:265–9. Katayama Y, Nakahara K, Shitamura T, Mukai S, Wakeda H, Yamashita Y, Inoue K, Nose K, Kamoto T. Effectiveness of acupuncture and moxibustion therapy for the treatment of refractory interstitial cystitis. Hinokika Kiyo. 2013;5:265–9.
43.
go back to reference Verghese TS, Riordain RN, Champaneria R, Latthe PM. Complementary therapies for bladder pain syndrome: a systematic review. Int Urogynecol J. 2015;27:1127–36.CrossRefPubMedPubMedCentral Verghese TS, Riordain RN, Champaneria R, Latthe PM. Complementary therapies for bladder pain syndrome: a systematic review. Int Urogynecol J. 2015;27:1127–36.CrossRefPubMedPubMedCentral
44.
go back to reference •• Komatsu E, Volpe K, Pahwa A. The effect of a diagnosis of interstitial cystitis/bladder pain syndrome: a qualitative approach [36d]. Obstet Gynecol. 2019. https://doi.org/10.1097/01.aog.0000558992.05634.39. (The authors of this study investigated if obtaining a clear diagnosis of IC/BPS could have an impact on patients’ symptom course and coping. Most patients noted an emotional benefit and improvements in treatment when they obtained a diagnosis. This study highlights the importance of validating patients’ experience and that providing them with a diagnosis can make them feel more engaged in their treatment, which appears to be therapeutic in and of itself.)CrossRef •• Komatsu E, Volpe K, Pahwa A. The effect of a diagnosis of interstitial cystitis/bladder pain syndrome: a qualitative approach [36d]. Obstet Gynecol. 2019. https://​doi.​org/​10.​1097/​01.​aog.​0000558992.​05634.​39. (The authors of this study investigated if obtaining a clear diagnosis of IC/BPS could have an impact on patients’ symptom course and coping. Most patients noted an emotional benefit and improvements in treatment when they obtained a diagnosis. This study highlights the importance of validating patients’ experience and that providing them with a diagnosis can make them feel more engaged in their treatment, which appears to be therapeutic in and of itself.)CrossRef
45.
go back to reference •• Hassani D, Flick L, Sangha H, Brown LA, Andy U, Arya L. How do women with interstitial cystitis/bladder pain syndrome make treatment choices? Int Urogynecol J. 2021;33:583–93. (The authors of this study explored the factors that could impact patient decision-making when choosing a treatment strategy for IC/BPS. There was a considerable interest amongst patients in self-management of symptoms, which empowered them to cope with IC/BPS despite more difficult periods. Patients wanted to take an active role in their treatment, where many of them would seek out educational resources where they could learn self-care practices.)CrossRefPubMedPubMedCentral •• Hassani D, Flick L, Sangha H, Brown LA, Andy U, Arya L. How do women with interstitial cystitis/bladder pain syndrome make treatment choices? Int Urogynecol J. 2021;33:583–93. (The authors of this study explored the factors that could impact patient decision-making when choosing a treatment strategy for IC/BPS. There was a considerable interest amongst patients in self-management of symptoms, which empowered them to cope with IC/BPS despite more difficult periods. Patients wanted to take an active role in their treatment, where many of them would seek out educational resources where they could learn self-care practices.)CrossRefPubMedPubMedCentral
46.
go back to reference Forrest JB, Moldwin R. Diagnostic options for early identification and management of interstitial cystitis/painful bladder syndrome. Int J Clin Pract. 2008;62:1926–34.CrossRefPubMed Forrest JB, Moldwin R. Diagnostic options for early identification and management of interstitial cystitis/painful bladder syndrome. Int J Clin Pract. 2008;62:1926–34.CrossRefPubMed
Metadata
Title
Quality, Value, and Efficacy of Complementary and Alternative Medicine in the Treatment of Interstitial Cystitis/Bladder Pain Syndrome
Authors
Béatrice Bouchard
Lysanne Campeau
Publication date
28-11-2022
Publisher
Springer US
Published in
Current Bladder Dysfunction Reports / Issue 1/2023
Print ISSN: 1931-7212
Electronic ISSN: 1931-7220
DOI
https://doi.org/10.1007/s11884-022-00683-2

Other articles of this Issue 1/2023

Current Bladder Dysfunction Reports 1/2023 Go to the issue

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Interstitial Cystitis/Bladder Pain Syndrome: What Today’s Urologist Should Know

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Antimicrobial Resistance in Urinary Tract Infections

Inflammatory/Infectious Bladder Disorders (MS Mourad, Section Editor)

Asymptomatic Bacteriuria: a Contemporary Review